Oncocross Co Ltd

382150

Company Profile

  • Business description

    Oncocross Co Ltd is innovating the drug development process through itsĀ AI approach for developing treatments for cancers, rare diseases, and intractable diseases, thereby contributing to a healthier world. Its Technology platforms include ONCOCROSS AI Platform, RAPTOR AI, ONCO-RAPTOR AI, and ONCOfind AI.

  • Contact

    Saechang-ro
    11, 15, 16th floor
    Mapo-gu
    Seoul
    KOR

    T: +82 28679967

    https://www.oncocross.com

  • Sector

    Technology

    Stock type

    Sensitive

  • Industry

    Software - Infrastructure

    Fiscal Year End

    31 December 2025

    Employees

    32

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,789.461.360.02%
DAX 4023,972.8165.38-0.27%
Dow JONES (US)42,101.572.870.01%
FTSE 1008,726.320.310.00%
HKSE23,573.38315.071.35%
NASDAQ19,244.89143.950.75%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,913.0224.470.42%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers